AION Labs AI drug-discovery venture studio
Research partnerships Deployment
Disclosed: Verified: Partners: AION Labs
Teva describes AION Labs, the venture studio it formed with AstraZeneca, Merck, Pfizer and other partners, and says DenovAI has developed an AI-physics platform to discover antibodies and proteins for conditions such as cancer and neurodegenerative illness.
Source
Company Archive pending